MedTrace Logo

DeVilbiss AutoAdjust With SmartFlex Comparative Study

NCT01203956 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2015-04-28

Study results available
· View outcomes & findings →

Summary

There will be equivalent therapeutic effectiveness between SmartFlex and standard modes when using the DeVilbiss AutoAdjust device.

Conditions

Interventions

DEVICE

SmartFlex

Device used with smartflex engaged.

DEVICE

Standard

Sponsors & Collaborators

  • DeVilbiss Healthcare LLC

    lead INDUSTRY

Principal Investigators

  • Leon Rosenthal, MD · Sleep Medicine Associates of Texas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01203956 on ClinicalTrials.gov